Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by TheRock07on May 13, 2016 7:41am
117 Views
Post# 24869185

Strong Seasonality in Drug Sales

Strong Seasonality in Drug SalesThis seasonality is provided by Horizon in its Q1 report and is well known to all who invest in health care stocks.

Q1 is the weakest quarter, accounting for about 20% of annual drug sales.

Q2 is significantly stronger, Q3 larger still and Q4 is the best quarter of the year.

In other words,CXR will see sequentially larger quarters in 2016 with  each being a record quarter.

With 4 new generics adding $80 million to sales in H2, there is a good chance of net earnings exceeding top line estimates
<< Previous
Bullboard Posts
Next >>